Lipoprotein(a), Coronary Complexity, and Stent-Related Outcomes: Meta-Analytic Insights for the Interventional Cardiologist
Journal of Clinical Medicine · 28.04.2026 · 15 (9) · 3359
DOI: 10.3390/jcm15093359 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 28.04.2026. Verfasst von Alberto Cereda und 9 weiteren Autor:innen. Beteiligte Einrichtung: Interventional Cardiology Unit, Department of Cardiology, San Carlo Borromeo Hospital, ASST Santi Paolo e Carlo, 20153 Milan, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Lipoprotein(a) [Lp(a)] is an inherited cardiovascular risk factor, but its relationship with coronary anatomical complexity, plaque phenotype, and outcomes after percutaneous coronary intervention (PCI) remains incompletely defined.
Methods
We conducted a systematic review and meta-analysis of studies evaluating the association between circulating Lp(a) levels and coronary disease characteristics, post-PCI clinical outcomes, stent-related adverse outcomes, and aortic valve disease.
Results
Twenty-six studies were included. Elevated Lp(a) levels were associated with greater coronary anatomical complexity and a higher risk of major adverse cardiovascular events after PCI (HR 1.4, 95% CI 1.2–1.7). The strongest associations were observed for stent-related adverse outcomes, including restenosis (OR 3.23, 95% CI 2.2–4.8) and target vessel revascularization (OR 2.6, 95% CI 1.6–4.4). Higher Lp(a) levels were also associated with vulnerable plaque features and aortic valve calcification.
Conclusions
Elevated Lp(a) is associated with greater coronary disease complexity and adverse outcomes after PCI. Elevated Lp(a) may represent a biological marker identifying high-risk patients and providing additional insight for personalized risk stratification and procedural decision-making in patients undergoing PCI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Interventional Cardiology Unit, Department of Cardiology, San Carlo Borromeo Hospital, ASST Santi Paolo e Carlo, 20153 Milan, Italy.
- Department of Cardiology, ASST Lariana, 22100 Como, Italy.
- Cardioangiologisches Centrum Bethanien (CCB), MVZ CCB Frankfurt und Main Taunus GbR, Markus Hospital, Wilhelm Epstein Strasse 4, 60431 Frankfurt am Main, Germany.
- Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, 56126 Pisa, Italy.
- Department of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, Italy.
- IRCCS Humanitas Research Hospital, 20089 Rozzano, Italy.
ORCID-Profile: Alberto Cereda, Matteo Rocchetti, Alessandro Sticchi
Zitieren
APA
Cereda, A., Stracqualursi, M., Rocchetti, M., Mariani, M., Carlà, M., Franchina, A. G., Carelli, M., Sticchi, A., Galli, M., & Lucreziotti, S. (2026). Lipoprotein(a), Coronary Complexity, and Stent-Related Outcomes: Meta-Analytic Insights for the Interventional Cardiologist. Journal of Clinical Medicine, 15(9), 3359. https://doi.org/10.3390/jcm15093359
Vancouver
Cereda A, Stracqualursi M, Rocchetti M, Mariani M, Carlà M, Franchina AG, et al. Lipoprotein(a), Coronary Complexity, and Stent-Related Outcomes: Meta-Analytic Insights for the Interventional Cardiologist. Journal of Clinical Medicine. 2026;15(9):3359. doi:10.3390/jcm15093359
BibTeX
@article{Cereda2026,
author = {Cereda, Alberto and Stracqualursi, Marco and Rocchetti, Matteo and Mariani, Margherita and Carlà, Matteo and Franchina, Antonio Gabriele and Carelli, Matteo and Sticchi, Alessandro and Galli, Mario and Lucreziotti, Stefano},
title = {Lipoprotein(a), Coronary Complexity, and Stent-Related Outcomes: Meta-Analytic Insights for the Interventional Cardiologist},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {9},
pages = {3359},
doi = {10.3390/jcm15093359}
}
EUVIMED